INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 414m ago
HOUSE PTR13m ago
SEC 13F13m ago
ROBINHOOD CHAIN13m ago
Corporate insider
DT

DiRaimondo Thomas

Chief Scientific OfficerCIK 0002005618

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 1
Max Insider Score36
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
DT
DiRaimondo ThomasChief Scientific Officer
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$34K
2,505 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Janux Therapeutics, Inc.Chief Scientific Officer · Jan 2, 2026
17
DT
DiRaimondo ThomasChief Scientific Officer
JANXJanux Therapeutics, Inc.
Grant or award
A
—
31.4K sh
Jan 2, 2026
Jan 2, 2026
traded Jan 2, 2026
+0d
SEC FORM 4

Evidence

9
DT
DiRaimondo ThomasChief Scientific Officer
JANXJanux Therapeutics, Inc.
Grant or award
A—
109.9K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC FORM 4

Evidence